Your browser doesn't support javascript.
loading
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.
Giaccone, Giuseppe; Kim, Chul; Thompson, Jillian; McGuire, Colleen; Kallakury, Bhaskar; Chahine, Joeffrey J; Manning, Maria; Mogg, Robin; Blumenschein, Wendy M; Tan, Ming T; Subramaniam, Deepa S; Liu, Stephen V; Kaplan, Ian M; McCutcheon, Justine N.
Afiliação
  • Giaccone G; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. Electronic address: gg496@georgetown.edu.
  • Kim C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Thompson J; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • McGuire C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Kallakury B; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Chahine JJ; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Manning M; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Mogg R; Merck and Co, Kenilworth, NJ, USA.
  • Blumenschein WM; Merck and Co, Kenilworth, NJ, USA.
  • Tan MT; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Subramaniam DS; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Liu SV; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Kaplan IM; Adaptive Biotechnologies, Seattle, WA, USA.
  • McCutcheon JN; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Lancet Oncol ; 19(3): 347-355, 2018 03.
Article em En | MEDLINE | ID: mdl-29395863

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timoma / Neoplasias do Timo / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article